Literature DB >> 1980114

A unique subset of normal murine CD4+ T cells lacking Thy-1 is expanded in a murine retrovirus-induced immunodeficiency syndrome, MAIDS.

K L Holmes1, H C Morse, M Makino, R R Hardy, K Hayakawa.   

Abstract

Some strains of mice inoculated with LP-BM5 murine leukemia virus (MuLV) develop a syndrome, termed mouse acquired immunodeficiency syndrome (MAIDS), characterized by progressive lymphoproliferation and profound immunodeficiency. LP-BM5 MuLV is a virus mixture that contains ecotropic (eco) and mink cell focus-induced MuLV and a defective genome that is the proximal cause of disease. Flow cytometry analyses of spleen and lymph nodes from susceptible C57BL/6 mice infected with this virus mixture revealed the presence in spleen and peripheral lymph nodes of a previously unrecognized subset of CD4+CD3+ T cells that are Thy-1-. The frequency of these cells increased with progression of disease, eventually comprising between 30% and 50% of all CD4+ cells. Infection of A/J mice, a strain which is genetically resistant to development of MAIDS, did not induce an increase of this T cell population, indicating that infection with the virus mixture was insufficient to induce its proliferation. A central role for the defective virus in this process was suggested by the finding that C57BL/6 mice infected with LP-BM5 eco alone did not have increased frequencies of Thy-1-CD4+ cells in spleen. Studies of spleen and peripheral lymph node cells from normal mice demonstrated the presence of Thy-1-CD4+ cells at frequencies of 1%-2%. Studies using two anti-T cell monoclonal antibodies, SM6C10 and SM3G11, that define four CD4+ subsets showed that Thy-1-CD4+ T cells from normal and infected mice were present only in the 6C10- subsets.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1980114     DOI: 10.1002/eji.1830201237

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Mice transgenic for a soluble form of murine cytotoxic T lymphocyte antigen 4 are refractory to murine acquired immune deficiency sydrome development.

Authors:  L De Leval; S Debrus; P Lane; J Boniver; M Moutschen
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

2.  CD28-B7 costimulatory blockade by CTLA4Ig delays the development of retrovirus-induced murine AIDS.

Authors:  L de Leval; S Colombi; S Debrus; M A Demoitié; R Greimers; P Linsley; M Moutschen; J Boniver
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

Review 3.  Cells and cytokines in the pathogenesis of MAIDS, a retrovirus-induced immunodeficiency syndrome of mice.

Authors:  H C Morse; N Giese; R Morawetz; Y Tang; R Gazzinelli; W K Kim; S Chattopadhyay; J W Hartley
Journal:  Springer Semin Immunopathol       Date:  1995

4.  STAT6-deficient mice exhibit normal induction of murine AIDS and expression of immunoglobulin E following infection with LP-BM5 murine leukemia viruses.

Authors:  H C Morse; T McCarty; N A Giese; L Taddesse-Heath; M J Grusby
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

5.  CD40-associated TRAF 6 signaling is required for disease induction in a retrovirus-induced murine immunodeficiency.

Authors:  Kathy A Green; Cory L Ahonen; W James Cook; William R Green
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

6.  Presence of transplantable T-lymphoid cells in C57BL/6 mice infected with murine AIDS virus.

Authors:  Y Kubo; Y Nakagawa; K Kakimi; H Matsui; M Iwashiro; K Kuribayashi; T Masuda; H Hiai; T Hirama; S Yanagawa
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

7.  Effects of exogenous, nonleukemogenic, ecotropic murine leukemia virus infections on the immune systems of adult C57BL/6 mice.

Authors:  J S Lee; N A Giese; K L Elkins; R A Yetter; K L Holmes; J W Hartley; H C Morse
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

8.  Murine AIDS is an antigen-driven disease: requirements for major histocompatibility complex class II expression and CD4+ T cells.

Authors:  N A Giese; T Giese; H C Morse
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

9.  Induction of murine acquired immunodeficiency syndrome (MAIDS) in allophenic mice generated from strains susceptible and resistant to disease.

Authors:  J M Sechler; A Lawler; J W Hartley; H C Morse; T C McCarty; R Swofford; A S Rosenberg
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

10.  In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS).

Authors:  R T Gazzinelli; N A Giese; H C Morse
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.